WP
BIIB icon

WMS Partners’s Biogen BIIB Stock Holding History

WMS Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-597
Closed -$211K – 187
2018
Q3 		$211K Buy
+597
New +$206K 0.02% 207
2016
Q3 		– Sell
-941
Closed -$228K – 191
2016
Q2 		$228K Buy
+941
New +$248K 0.03% 187
2015
Q3 		– Sell
-3,600
Closed -$1.45M – 206
2015
Q2 		$1.45M Buy
3,600
+52
+1% +$20.9K 0.17% 98
2015
Q1 		$1.5M Buy
+3,548
New +$1.4M 0.18% 94

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WMS Partners's BIIB Position: Q4 2018 in Review

WMS Partners sold out of Biogen (BIIB) in Q4 2018, closing a stake of 597 shares — an estimated $211K sold.

WMS Partners first reported a position in BIIB in Q1 2015 and held it in 4 quarters. The position peaked at $1.5M in Q1 2015. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • WMS Partners reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • WMS Partners sold 597 Biogen shares in Q4 2018, an estimated $211K.
  • WMS Partners first reported a position in Biogen in Q1 2015 and held it in 4 quarters.
  • WMS Partners's Biogen position peaked at $1.5M in Q1 2015.
  • 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on WMS Partners's 13F filing for Q4 2018, filed 14 Feb 2019.